Last reviewed · How we verify
Measles-Rubella vaccine Bio Farma
Measles-Rubella vaccine Bio Farma is a Biologic drug developed by PT Bio Farma. It is currently in Phase 2 development. Also known as: Vaksin Campak Rubella Bio Farma.
At a glance
| Generic name | Measles-Rubella vaccine Bio Farma |
|---|---|
| Also known as | Vaksin Campak Rubella Bio Farma |
| Sponsor | PT Bio Farma |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Immunogenicity & Safety of Bio Farma's Measles-Rubella (MR) Vaccine in Indonesian Infants (Bridging Study) (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Measles-Rubella vaccine Bio Farma CI brief — competitive landscape report
- Measles-Rubella vaccine Bio Farma updates RSS · CI watch RSS
- PT Bio Farma portfolio CI
Frequently asked questions about Measles-Rubella vaccine Bio Farma
What is Measles-Rubella vaccine Bio Farma?
Measles-Rubella vaccine Bio Farma is a Biologic drug developed by PT Bio Farma.
Who makes Measles-Rubella vaccine Bio Farma?
Measles-Rubella vaccine Bio Farma is developed by PT Bio Farma (see full PT Bio Farma pipeline at /company/pt-bio-farma).
Is Measles-Rubella vaccine Bio Farma also known as anything else?
Measles-Rubella vaccine Bio Farma is also known as Vaksin Campak Rubella Bio Farma.
What development phase is Measles-Rubella vaccine Bio Farma in?
Measles-Rubella vaccine Bio Farma is in Phase 2.
Related
- Manufacturer: PT Bio Farma — full pipeline
- Also known as: Vaksin Campak Rubella Bio Farma